Article
Dundee, Scotland - A routine cell culture of a patient with epidermolysis bullosa simplex (EBS) has led to the inadvertent discovery of a revertant mutation that deactivates the original pathogenic mutation, according to Irwin McLean, Ph.D.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.